Palisade Bio Inc. (NASDAQ: PALI) Stock Information | RedChip

Palisade Bio Inc. (NASDAQ: PALI) Listen to this Section


$3.94
+0.2250 ( +6.07% ) 19.2K

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Market Data


Open


$3.94

Previous close


$3.71

Volume


19.2K

Market cap


$3.69M

Day range


$3.53 - $3.95

52 week range


$3.30 - $28.95

Insider Ownership Transactions

Total Amount Purchased: -9,033.00 | $ -35,544.86

Date Type Amount Purchased Purchaser
2023-09-13 Sale -5558.00 Finley John David
2023-08-14 Sale -3475.00 Finley John David

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Dec 19, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023
4 Insider transactions 1 Nov 24, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.